Serum 25-Hydroxyvitamin D and the Incidence of Acute Viral Respiratory Tract Infections in Healthy Adults
Сывороточный уровень 25-гидроксивитамина D и частота острых вирусных инфекций дыхательных путей у здоровых взрослых
2010-06-14
SCID: 54.1/b3ncbm4w
Discuss with AI
25-hydroxyvitamin Dacute viral respiratory tract infectionsinfluenzaprospective cohort studyvitamin D supplementation
Figures from the paper
Abstract (AI)
BACKGROUND: Declining serum concentrations of 25-hydroxyvitamin D seen in the fall and winter as distance increases from the equator may be a factor in the seasonal increased prevalence of influenza and other viral infections. This study was done to determine if serum 25-hydroxyvitamin D concentrations correlated with the incidence of acute viral respiratory tract infections. METHODOLOGY/FINDINGS: In this prospective cohort study serial monthly concentrations of 25-hydroxyvitamin D were measured over the fall and winter 2009-2010 in 198 healthy adults, blinded to the nature of the substance being measured. The participants were evaluated for the development of any acute respiratory tract infections by investigators blinded to the 25-hydroxyvitamin D concentrations. The incidence of infection in participants with different concentrations of vitamin D was determined. One hundred ninety-five (98.5%) of the enrolled participants completed the study. Light skin pigmentation, lean body mass, and supplementation with vitamin D were found to correlate with higher concentrations of 25-hydroxyvitamin D. Concentrations of 38 ng/ml or more were associated with a significant (p<0.0001) two-fold reduction in the risk of developing acute respiratory tract infections and with a marked reduction in the percentages of days ill. CONCLUSIONS/SIGNIFICANCE: Maintenance of a 25-hydroxyvitamin D serum concentration of 38 ng/ml or higher should significantly reduce the incidence of acute viral respiratory tract infections and the burden of illness caused thereby, at least during the fall and winter in temperate zones. The findings of the present study provide direction for and call for future interventional studies examining the efficacy of vitamin D supplementation in reducing the incidence and severity of specific viral infections, including influenza, in the general population and in subpopulations with lower 25-hydroxyvitamin D concentrations, such as pregnant women, dark skinned individuals, and the obese.
Key Findings
1
In a prospective cohort of 198 healthy adults, 195 participants completed monthly vitamin D and respiratory infection monitoring during fall and winter 2009–2010.
2
Light skin pigmentation, lean body mass, and vitamin D supplementation were associated with higher serum 25-hydroxyvitamin D concentrations.
3
Participants with concentrations of at least 38 ng/ml experienced markedly fewer days of illness.
4
Serum 25-hydroxyvitamin D concentrations of at least 38 ng/ml were associated with a significant (p<0.0001) two-fold reduction in acute viral respiratory tract infection risk.
5
The findings support future interventional studies testing whether vitamin D supplementation reduces the incidence and severity of specific viral infections, including influenza.
Research Object
Serum 25-hydroxyvitamin D concentrations and acute viral respiratory tract infections in healthy adults during fall and winter
Research Subject
The association of serum 25-hydroxyvitamin D concentrations, particularly levels of 38 ng/ml or higher, with the incidence and duration of acute viral respiratory tract infections
Publication Details
Publication Date
2010-06-14
Journal
Publisher
ISSN
Cited by
427
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest